IP Library Granted Patent US 11,964,017
Granted Patent B2
US 11,964,017 · App. 18/487,887 · Granted Apr 23, 2024

Compositions and methods for treatment of neurological disorders

Inventors: Lilit Garibyan (Newton, MA); Richard Rox Anderson (Boston, MA); William A. Farinelli (Boston, MA); Emilia Javorsky (Watertown, MA)
Assignee: The General Hospital Corporation
A61K45/06A61K9/0019A61K9/0024A61K31/045A61K31/047A61K31/137A61K31/167A61K31/245A61K31/445A61K31/7004A61K31/718A61K31/765A61K33/00A61K47/02A61K47/10A61K47/18A61K47/26A61K47/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,964,017
App. No.
18/487,887
Granted
Apr 23, 2024
Kind
B2
Abstract

Described herein are compositions comprising, and methods for using, biocompatible cold slurries and methods of administering the same to provide reversible inhibition of peripheral nerves in a subject in need thereof.

Claims (42)

1. A method comprising:

accessing tissue comprising one or more peripheral nerves; and

injecting a biocompatible ice slurry around the one or more peripheral nerves, wherein:

the biocompatible ice slurry is configured to cool the one or more peripheral nerves for a duration sufficient to inhibit the one or more peripheral nerves in the subject; and

said inhibition is reversible.

2. The method of claim 1 , wherein injecting the biocompatible ice slurry around the one or more peripheral nerves comprises providing the biocompatible ice slurry along a perineural sheath of the one or more peripheral nerves.

3. The method of claim 1 , wherein the one or more peripheral nerves are at least one of subcutaneous nerves, autonomic nerves, or somatic nerves.

4. The method of claim 1 , wherein the biocompatible ice slurry is configured to cool the one or more peripheral nerves to a temperature sufficient to crystallize a plurality of lipids of a myelin sheath of the one or more peripheral nerves.

5. The method of claim 1 , wherein the biocompatible ice slurry is configured to cool the one or more peripheral nerves to a temperature of between about 5° C. and about −40° C.

6. The method of claim 1 , wherein the biocompatible ice slurry is configured to have a first equilibration temperature of between about 4° C. and about −30° C.

7. The method of claim 6 , wherein the biocompatible ice slurry is configured to have a second equilibration temperature of between about 2° C. and about −30° C.

8. The method of claim 1 , wherein the duration sufficient to inhibit the one or more peripheral nerves in the subject is at least about 5 minutes.

9. The method of claim 1 , wherein the biocompatible ice slurry comprises a plurality of ice crystals.

10. The method of claim 9 , wherein the biocompatible ice slurry is configured to cool the one or more peripheral nerves by tissue cooling, wherein the tissue cooling comprises a first heat exchange stage, a second heat exchange stage, and a third heat exchange stage, wherein:

(i) the first heat exchange stage comprises reaching a local equilibrium temperature by rapid equilibration between the biocompatible ice slurry and the tissue, wherein at least some of the ice of the biocompatible ice slurry melts;

(ii) the second heat exchange stage comprises maintaining the local equilibrium temperature, wherein the remaining ice of the biocompatible ice slurry melts; and

(iii) the third heat exchange stage comprises gradually warming the tissue.

11. The method of claim 1 , wherein the biocompatible ice slurry is configured to cool the one or more peripheral nerves by tissue cooling, wherein the tissue cooling comprises:

(i) exchanging heat stored by a heat capacity of the biocompatible ice slurry and the tissue;

(ii) exchanging heat released by crystallization of one or more lipids of the tissue or one or more lipids of a myelin sheath of the one or more peripheral nerves; and

(iii) exchanging heat absorbed by melting of the biocompatible ice slurry.

12. A method comprising:

accessing tissue comprising one or more peripheral nerves; and

administering a biocompatible ice slurry around the one or more peripheral nerves, wherein:

the biocompatible ice slurry is configured to cool the one or more peripheral nerves for a duration sufficient to inhibit the one or more peripheral nerves in the subject; and

said inhibition is reversible.

13. The method of claim 12 , wherein administering the biocompatible ice slurry around the one or more peripheral nerves comprises injecting the biocompatible ice slurry into a tissue having the one or more peripheral nerves.

14. The method of claim 12 , wherein administering the biocompatible ice slurry around the one or more peripheral nerves comprises providing the biocompatible ice slurry along a perineural sheath of the one or more peripheral nerves.

15. The method of claim 12 , wherein the biocompatible ice slurry is configured to cool the one or more peripheral nerves to a temperature sufficient to crystallize a plurality of lipids of a myelin sheath of the one or more peripheral nerves.

16. The method of claim 12 , wherein the biocompatible ice slurry is configured to cool the one or more peripheral nerves to a temperature of between about 5° C. and about −40° C.

17. The method of claim 12 , wherein the biocompatible ice slurry has a first equilibration temperature of between about 4° C. and about −30° C.

18. The method of claim 17 , wherein the biocompatible ice slurry has a second equilibration temperature of between about 2° C. and about −30° C.

19. The method of claim 12 , wherein the duration sufficient to inhibit the one or more peripheral nerves in the subject is at least about 5 minutes.

20. The method of claim 12 , wherein the biocompatible ice slurry comprises a plurality of ice crystals.

21. The method of claim 20 , wherein the biocompatible ice slurry is configured to cool the one or more peripheral nerves by tissue cooling, wherein the tissue cooling comprises a first heat exchange stage, a second heat exchange stage, and a third heat exchange stage, wherein:

(i) the first heat exchange stage comprises reaching a local equilibrium temperature by rapid equilibration between the biocompatible ice slurry and the tissue, wherein at least some of the ice of the biocompatible ice slurry melts;

(ii) the second heat exchange stage comprises maintaining the local equilibrium temperature, wherein the remaining ice of the biocompatible ice slurry melts; and

(iii) the third heat exchange stage comprises gradually warming the tissue.

22. The method of claim 12 , wherein the biocompatible ice slurry is configured to cool the one or more peripheral nerves by tissue cooling, wherein the tissue cooling comprises:

(i) exchanging heat stored by a heat capacity of the biocompatible ice slurry and the tissue;

(ii) exchanging heat released by crystallization of one or more lipids of the tissue or one or more lipids of a myelin sheath of the one or more peripheral nerves; and

(iii) exchanging heat absorbed by melting of the biocompatible ice slurry.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2023
From: GARIBYAN, LILIT; ANDERSON, RICHARD ROX; FARINELLI, WILLIAM A.; JAVORSKY, EMILIA
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 065941/0682 →
Continuity (6)
Continuation 17236567 · Apr 21, 2021
Continuation 15505039
Provisional Application 62121472 · Feb 26, 2015
Provisional Application 62121329 · Feb 26, 2015
Provisional Application 62042979 · Aug 28, 2014
Related Publication 20240042034A1 · Feb 8, 2024
Cited By (2)
US 12,611,375 US 12,697,247